
Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their platform offers a community-driven approach, allowing users to fine-tune and integrate these models into their workflows, thereby enhancing research capabilities in the biological sciences. With a commitment to accessibility and collaboration, Helical positions itself as a key player in the AI for bio sector, catering to researchers and developers looking for innovative solutions.

Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their platform offers a community-driven approach, allowing users to fine-tune and integrate these models into their workflows, thereby enhancing research capabilities in the biological sciences. With a commitment to accessibility and collaboration, Helical positions itself as a key player in the AI for bio sector, catering to researchers and developers looking for innovative solutions.
What they do: Platform for Bio Foundation Models enabling in-silico experiments for drug discovery and R&D
HQ: Luxembourg
Stage / funding: Seed (closed Jun 28, 2024)
Founders: Mathieu Klop; Maxime Allard; Rick Schneider
| Company |
|---|
Drug discovery and pharmaceutical R&D using AI-driven in-silico experiments
2024
Biotechnology Research
Reported seed round with seven investors
“Has participation from early-stage investors and angel/backer set including Frst and named investors”